切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 309 -313. doi: 10.3877/cma.j.issn.1674-1358.2024.05.008

病例报告

肺炎支原体诱发反应性感染性皮疹黏膜疹一例
张胜伟1, 孟召路1, 热汗古丽·吾休尔1, 万世森1, 闫鹏1, 阳乔1,2,()   
  1. 1.843300 阿拉尔市,浙江大学医学院附属邵逸夫医院新疆兵团阿拉尔医院感染科
    2.310016 杭州市,浙江大学医学院附属邵逸夫医院肝病感染科
  • 收稿日期:2024-05-31 出版日期:2024-10-15
  • 通信作者: 阳乔
  • 基金资助:
    省部共建中亚高发病成因与防治国家重点实验室开放课题资助项目(No. SKL-HIDCA-2023-ALE2)浙江省基础公益研究计划(No. LY21H030011)浙江省医药卫生科技青年创新人才支持计划项目(No. 2022RC196)

A case of Mycoplasma pneumoniae-induced reactive infectious mucocutaneous eruption

Shengwei Zhang1, Zhaolu Meng1, Shisen Wan1, Peng Yan1, Qiao Yang1,2,()   

  1. 1.Department of Infectious Diseases, Zhejiang University Sir Run Run Shaw Alaer Hospital, Alaer 843300, China
    2.Department of Infectious Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016,China
  • Received:2024-05-31 Published:2024-10-15
  • Corresponding author: Qiao Yang
引用本文:

张胜伟, 孟召路, 热汗古丽·吾休尔, 万世森, 闫鹏, 阳乔. 肺炎支原体诱发反应性感染性皮疹黏膜疹一例[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 309-313.

Shengwei Zhang, Zhaolu Meng, Shisen Wan, Peng Yan, Qiao Yang. A case of Mycoplasma pneumoniae-induced reactive infectious mucocutaneous eruption[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(05): 309-313.

目的

提高临床对肺炎支原体感染引起反应性感染性皮肤黏膜疹(RIME)的认知,从而对该病进行更准确的治疗和预后判断。

方法

回顾性分析浙江大学医学院附属邵逸夫医院新疆兵团阿拉尔医院2024年4月11日收治的1例肺炎支原体感染引起RIME患者的临床资料、诊疗经过和预后。

结果

患者,女性、15岁,因发热、咳嗽伴黏膜糜烂起病,实验室检查显示血清肺炎支原体IgM抗体阳性,咽拭子肺炎支原体DNA扩增试验阳性,肺部CT显示多发斑片密度增高影,肺炎支原体肺炎诊断成立。病程中患者同时伴发水疱疹、靶形疹和黏膜溃烂,结合肺炎支原体感染的实验室证据,支持RIME诊断。患者接受多西环素抗感染,短程、中等剂量的皮质类固醇联合免疫球蛋白治疗,痊愈出院。

结论

肺炎支原体感染引起的RIME可通过多西环素、皮质类固醇和免疫球蛋白治疗有效控制,预后良好。

Objective

To improve clinical understanding of reactive infectious skin and mucous membrane rash (RIME) caused by Mycoplasma pneumoniae infection, and to provide more accurate treatment and prognosis assessment for this disease.

Methods

A retrospective analysis was conducted on clinical data,treatment and prognosis of a patient with RIME caused by Mycoplasma pneumoniae infection, who was admitted to the Zhejiang University Sir Run Run Shaw Alaer Hospital, on April 11th, 2024.

Results

The 15-year-old female patient presented with symptoms indicative of fever, cough and mucosal ulceration.Subsequent laboratory investigations revealed the presence of positive serum IgM antibodies to Mycoplasma pneumoniae and a positive result for a Mycoplasma pneumoniae DNA amplification test conducted on throat swabs. Chest computed tomography (CT) scan revealed the presence of multiple patchy opacities, which were consistent with the imaging characteristics of Mycoplasma pneumoniae pneumonia. Throughout the clinical course, the patient exhibited a constellation of cutaneous lesions, including vesicular eruptions, targetoid lesions and mucocutaneous ulcerations. The diagnosis of RIME was supported by the combined evidence of laboratory findings indicative of a Mycoplasma pneumoniae infection. The patient was treated with doxycycline for its antibacterial properties, in conjunction with a brief course of moderate-dose corticosteroids and intravenous immunoglobulin therapy. This resulted in a complete recovery and subsequent discharge from the hospital.

Conclusions

RIME caused by Mycoplasma pneumoniae infection can be effectively managed with doxycycline, corticosteroids and immunoglobulin therapy, with a favorable prognosis.

表1 本例患者诊治过程中血常规和炎症指标
表2 本例患者的诊治方案
图1 患者发病后皮肤黏膜变化 注:双眼结膜炎,口咽部泛发溃疡,嘴唇肿胀、渗出、溃烂致张口困难。手背、上肢、后背散布水疱性皮损、靶形疹。发病1个月后,黏膜皮肤病变消退
图2 患者治疗前后的肺部CT影像学 注:A:2024年4月11日(治疗前,发病第5天)肺部CT显示两肺多发边缘模糊结节及斑片状密度增高影(如蓝色箭头所示),部分实变(如红色箭头所示),以左肺上叶及右肺中叶为主。B:2024年5月6日(治疗后,发病第30 d)肺部CT显示两肺感染性病灶较前片吸收好转,伴右肺中叶局限性不张(如红色箭头所示)
[1]
Canavan TN, Mathes EF, Frieden I, et al. Mycoplasma pneumoniaeinduced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme:a systematic review[J].J Am Acad Dermatol,2015,72(2):239-245.
[2]
Amode R, Ingen-Housz-Oro S, Ortonne N, et al. Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme:A single-center series of 33 cases compared with 100 cases induced by other causes[J]. J Am Acad Dermatol,2018,79(1):110-117.
[3]
Kim K, Jung S, Kim M, et al. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections:A systematic review and Meta-analysis[J]. JAMA Netw Open,2022,5(7):e2220949.
[4]
Ramien ML. Reactive infectious mucocutaneous eruption:Mycoplasma pneumoniae-induced rash and mucositis and other parainfectious eruptions[J]. Clin Exp Dermatol,2021,46(3):420-429.
[5]
Canavan TN, Mathes EF, Frieden I, et al. Mycoplasma pneumoniaeinduced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme:a systematic review[J].J Am Acad Dermatol,2015,72(2):239-245.
[6]
Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia[J]. JAMA,2020,323(9):885-886.
[7]
Chen Y, Li X, Fu Y, et al. Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China[J]. Lancet Microbe,2024,5(9):100870.
[8]
Wang Y, Xu B, Wu X, et al. Increased macrolide resistance rate of M3562 Mycoplasma pneumoniae correlated with macrolide usage and genotype shifting[J]. Front Cell Infect Microbiol,2021,11:675466.
[9]
程欣, 王碧航, 赵先进. 肺炎支原体血清学标志物研究进展[J/CD].中华实验和临床感染病杂志(电子版),2019,13(4):265-268.
[10]
Blackmore TK, Reznikov M, Gordon DL. Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection[J]. Pathology,1995,27(2):177-181.
[11]
Ito Y, Iwashima S, Hayano S, et al. Rapid detection of the macrolide sensitivity of pneumonia-causing Mycoplasma pneumoniae using quenching probe polymerase chain reaction (GENECUBE®)[J]. Mol Diagn Ther,2018,22(6):737-747.
[12]
Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection[J].BMC Microbiol,2008,8:93.
[13]
Valle J, Nasrollahi F, Eilbert W. Mycoplasma pneumoniae-induced rash and mucositis[J]. Am J Emerg Med,2022,54:324.e5-324.e7.
[14]
Yang J, Hooper WC, Phillips DJ, et al. Cytokines in Mycoplasma pneumoniae infections[J]. Cytokine Growth Factor Rev,2004,15(2-3):157-168.
[15]
Luo Y, Li C, Zhou Z, et al. Biological functions of IL-17-producing cells in mycoplasma respiratory infection[J]. Immunology,2021,164(2):223-230.
[16]
Hu J, Ye Y, Chen X, et al. Insight into the pathogenic mechanism of Mycoplasma pneumoniae[J]. Curr Microbiol,2022,80(1):14.
[17]
Canavan TN, Mathes EF, Frieden I,et al. Mycoplasma pneumoniaeinduced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme:a systematic review[J].J Am Acad Dermatol,2015,72(2):239-245.
[18]
Santos RP, Silva M, Vieira AP, et al. Mycoplasma pneumoniaeinduced rash and mucositis:a recently described entity[J]. BMJ Case Rep,2017,2017:bcr2017220768.
[19]
Zão I, Ribeiro F, Rocha V, et al. Mycoplasma pneumoniae-associated mucositis:A recently described entity[J]. Eur J Case Rep Intern Med,2018,5(11):000977.
[20]
Grünwald P, Mockenhaupt M, Panzer R, et al. Erythema multiforme,Stevens-Johnson syndrome/toxic epidermal necrolysis--diagnosis and treatment[J]. J Dtsch Dermatol Ges,2020,18(6):547-553.
[21]
Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis[J]. Clin Dermatol,2020,38(6):607-612.
[22]
Frantz R, Huang S, Are A, et al. Stevens-Johnson Syndrome and toxic epidermal necrolysis:A review of diagnosis and management[J].Medicina (Kaunas),2021,57(9):895.
[1] 张烈, 严一核, 杜洁瑜. 分泌型白细胞蛋白酶抑制因子对无创呼吸机治疗重症肺炎患者的预测效能[J]. 中华危重症医学杂志(电子版), 2024, 17(04): 301-306.
[2] 高娟, 郑枫, 张晴, 朱琳娜, 王娴. 三种常用临床指标在重症肺炎患者液体管理监测中的比较研究[J]. 中华危重症医学杂志(电子版), 2024, 17(03): 204-210.
[3] 李世杰, 申传安. 烧伤合并吸入性损伤患者呼吸机相关肺炎的研究现状[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 351-355.
[4] 郑宝英, 黄小兰, 贾楠, 朱春梅. 儿童难治性肺炎支原体肺炎早期预警指标[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 215-221.
[5] 徐保平, 彭怀文, 喻怀斌, 王晓涛. 新型冠状病毒肺炎继发糖尿病酮症酸中毒合并肝门静脉积气一例[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 250-255.
[6] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[7] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[8] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[9] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[10] 晏彦, 杨军, 周凤兰, 孙登昆, 陈玉. 哌拉西林他唑巴坦和哌拉西林舒巴坦治疗细菌性肺炎的倾向性匹配分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 817-819.
[11] 燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[12] 张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[13] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[14] 王蕊, 林先萍, 李盼盼. 铜绿假单胞菌感染肺炎菌血症危险因素及耐药性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 478-480.
[15] 段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
阅读次数
全文


摘要